Literature DB >> 8989245

Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.

S Fisker1, N Vahl, J O Jørgensen, J S Christiansen, H Orskov.   

Abstract

The circulating high affinity GH-binding protein (GHBP), which derives from the extracellular domain of the hepatic GH receptor, correlates inversely to GH levels and directly to body mass index (BMI) in healthy adults. As GH secretion and adiposity are also interrelated, we tested the hypothesis that body composition more than GH, determines GHBP levels in healthy adults. Forty-two healthy adults [21 females and 21 males; mean age, 39.4 yr range, 27-59 yr); mean BMI, 23.9 kg/m2 (range, 18.9-34.7 kg/m2)], underwent anthropometric measurements (BMI, W/H ratio, computed tomography scan, dual energy x-ray absortiometry (DEXA) scan, and bioimpedance) in addition to two GH stimulation tests (arginine and clonidine) and a 24-h GH profile. By simple linear regression, serum GHBP correlated positively to several indices of adiposity: intraabdominal fat (r = 0.537; P = 0.001), sc abdominal fat (r = 0.680; P < 0.001), BMI (r = 0.483; P = 0.001), W/H ratio (r = 0.452; P = 0.003), total body fat (DEXA scanning; r = 0.503; P = 0.002), and body fat (bioimpedance; r = 0.354; P = 0.023). Lean body mass estimated by DEXA scan was negatively associated with GHBP (r = 0.541; P < 0.001). GHBP was inversely proportional to arginine-stimulated GH release (r = -0.346; P = 0.027) and negatively associated with several measures of spontaneous GH release as estimated by deconvolution analysis (GH mass, GH production rate, and mean GH; r = -0.371; P = 0.017, r = -0.393; P = 0.011, and r = -0.343; P = 0.028, respectively)). With multiple linear regression analyses, indices of adiposity were significant determinants of GHBP levels, whereas GH status did not contribute independently to the prediction of GHBP. Neither insulin-like growth factor I nor fasting insulin levels correlated to GHBP levels. In conclusion, GHBP levels in normal adults seem to be determined by abdominal fat mass rather than GH secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989245     DOI: 10.1210/jcem.82.1.3657

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy.

Authors:  W R De Vries; H P Koppeschaar; E Bol; C A Roelen; G H Donker; M E Doerga; M Osman-Dualeh; Y E Snel
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

Review 2.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Authors:  Ralph Rabkin; Di Fei Sun; Yu Chen; Jane Tan; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

3.  GH-binding protein is related to bone mineral density in non-obese androgenized women.

Authors:  M Legan; J Osredkar; S Fisker; A Kocijancic
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

Review 4.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 5.  Obesity, growth hormone and exercise.

Authors:  Gwendolyn A Thomas; William J Kraemer; Brett A Comstock; Courtenay Dunn-Lewis; Carl M Maresh; Jeff S Volek
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

6.  Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Authors:  Rasmus Juul Kildemoes; Christian Hollensen; Beverly M K Biller; Gudmundur Johannsson; Yutaka Takahashi; Michael Højby Rasmussen
Journal:  Eur J Endocrinol       Date:  2022-05-16       Impact factor: 6.558

7.  Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome.

Authors:  Jessica K Devin; Hui Nian; Jorge E Celedonio; Patricia Wright; Nancy J Brown
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

Review 8.  The Role of Growth Hormone in Mesenchymal Stem Cell Commitment.

Authors:  Simona Bolamperti; Francesca Guidobono; Alessandro Rubinacci; Isabella Villa
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.